Trevi Therapeutics, Inc. is a company that provides Clinical trial, Nalbuphine, Counterirritant and more. Trevi Therapeutics, Inc. is headquartered in United States Connecticut. Trevi Therapeutics, Inc. was founded in 2011. Trevi Therapeutics, Inc. has a total of 131 patents and 1 literature
Trevi Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically...
What is Trevi Therapeutics, Inc.'s official website?